• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复发性流产女性活产预后:什么是最佳的成功衡量指标?

Prognosis for live birth in women with recurrent miscarriage: what is the best measure of success?

机构信息

The Fertility Clinic, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, 2100 Copenhagen, Denmark.

出版信息

Obstet Gynecol. 2012 Jan;119(1):37-43. doi: 10.1097/AOG.0b013e31823c0413.

DOI:10.1097/AOG.0b013e31823c0413
PMID:22183209
Abstract

OBJECTIVE

To establish a method of estimating the proportion of women with a subsequent live birth after a well-defined time period in an open cohort of women referred to a tertiary recurrent miscarriage clinic.

METHODS

We performed a descriptive cohort study with register-based follow-up at a tertiary center for investigation and treatment of recurrent miscarriage in Denmark. All women with primary or secondary recurrent miscarriage referred to the clinic from 1986 to 2008 were included in the study (n=987). Main outcome measures were age-specific and miscarriage-specific proportions of women with a live birth after the first consultation and similar hazard ratios compared with the prognosis in women aged 30-34 years with three miscarriages before the first consultation.

RESULTS

Five years after the first consultation, 66.7% (95% confidence interval [CI] 63.7-69.7) had achieved a live birth, increasing to 71.1% (95% CI 68.0-74.2) 15 years after the first consultation. There was a significantly decreased chance of at least one subsequent live birth with increasing maternal age (log-rank P<.01) and increasing number of miscarriages (log-rank P<.01) at first consultation.

CONCLUSION

Approximately two thirds of women with recurrent miscarriage referred to a tertiary center succeed in having at least one live birth within 5 years after their first consultation. Our study allows for a descriptive overview of the course of live birth outcome in women with recurrent miscarriage, but not for evaluation of the effect of treatment.

摘要

目的

在丹麦一家复发性流产三级诊疗中心,通过开放队列对转诊至该中心的女性进行随访,建立一种估算在明确时间段后活产比例的方法。

方法

我们进行了一项描述性队列研究,以丹麦一家复发性流产三级诊疗中心的登记数据为基础进行随访。该研究纳入了 1986 年至 2008 年所有因原发性或继发性复发性流产而转诊至该诊所的女性(n=987)。主要结局指标为首次就诊后不同年龄和不同流产次数的女性活产比例,以及与首次就诊时发生过三次流产且年龄在 30-34 岁的女性相比,相似的风险比。

结果

首次就诊后 5 年,66.7%(95%置信区间[CI] 63.7-69.7)的女性活产,首次就诊后 15 年活产率增加至 71.1%(95% CI 68.0-74.2)。随着产妇年龄(对数秩 P<.01)和首次就诊时流产次数(对数秩 P<.01)的增加,至少有一次后续活产的机会显著降低。

结论

约三分之二转诊至三级中心的复发性流产女性在首次就诊后 5 年内至少有一次活产。本研究可对复发性流产女性的活产结局过程进行描述性概述,但无法评估治疗效果。

相似文献

1
Prognosis for live birth in women with recurrent miscarriage: what is the best measure of success?复发性流产女性活产预后:什么是最佳的成功衡量指标?
Obstet Gynecol. 2012 Jan;119(1):37-43. doi: 10.1097/AOG.0b013e31823c0413.
2
Non-visualized pregnancy losses are prognostically important for unexplained recurrent miscarriage.对于不明原因的复发性流产,未可视化的妊娠丢失在预后方面具有重要意义。
Hum Reprod. 2014 May;29(5):931-7. doi: 10.1093/humrep/deu042. Epub 2014 Mar 6.
3
Time to conception and time to live birth in women with unexplained recurrent miscarriage.不明原因复发性流产女性的临床妊娠时间和活产时间。
Hum Reprod. 2014 Jun;29(6):1146-52. doi: 10.1093/humrep/deu052. Epub 2014 Mar 28.
4
A combination treatment of prednisone, aspirin, folate, and progesterone in women with idiopathic recurrent miscarriage: a matched-pair study.泼尼松、阿司匹林、叶酸和孕酮联合治疗特发性复发性流产女性:一项配对研究。
Fertil Steril. 2006 Jul;86(1):145-8. doi: 10.1016/j.fertnstert.2005.12.035. Epub 2006 May 23.
5
Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial.复发性流产患者血栓前状态的预防治疗:有无血栓形成倾向的妇女。HABENOX:一项随机多中心试验。
Thromb Haemost. 2011 Feb;105(2):295-301. doi: 10.1160/TH10-05-0334. Epub 2010 Nov 23.
6
A firstborn boy is suggestive of a strong prognostic factor in secondary recurrent miscarriage: a confirmatory study.头胎为男孩提示继发性复发性流产中存在一个强有力的预后因素:一项验证性研究。
Fertil Steril. 2008 Apr;89(4):907-11. doi: 10.1016/j.fertnstert.2007.04.029. Epub 2008 Jan 28.
7
Aspirin plus heparin or aspirin alone in women with recurrent miscarriage.阿司匹林联合肝素或阿司匹林单独用于复发性流产的女性。
N Engl J Med. 2010 Apr 29;362(17):1586-96. doi: 10.1056/NEJMoa1000641. Epub 2010 Mar 24.
8
Impact of the sex of first child on the prognosis in secondary recurrent miscarriage.头胎性别对继发性复发性流产预后的影响。
Hum Reprod. 2004 Dec;19(12):2946-51. doi: 10.1093/humrep/deh516. Epub 2004 Oct 28.
9
Midluteal serum progesterone concentration does not predict the outcome of pregnancy in women with unexplained recurrent miscarriage.不明原因复发性流产妇女的黄体中期血清孕激素浓度不能预测妊娠结局。
Reprod Biomed Online. 2013 Feb;26(2):138-41. doi: 10.1016/j.rbmo.2012.10.018. Epub 2012 Nov 1.
10
Frequency and impact of obstetric complications prior and subsequent to unexplained secondary recurrent miscarriage.不明原因复发性流产前和后产科并发症的频率和影响。
Hum Reprod. 2010 Jun;25(6):1543-52. doi: 10.1093/humrep/deq091. Epub 2010 Apr 14.

引用本文的文献

1
Fertility, time to pregnancy, and pregnancy outcomes among women with recurrent miscarriages in the UK: a prospective observational longitudinal study.英国复发性流产女性的生育力、受孕时间及妊娠结局:一项前瞻性观察性纵向研究
Lancet Reg Health Eur. 2025 Jun 26;55:101343. doi: 10.1016/j.lanepe.2025.101343. eCollection 2025 Aug.
2
Comparative analysis of cumulative live birth rates in patients with recurrent pregnancy loss undergoing preimplantation genetic testing for aneuploidy versus conventional in vitro fertilisation/intracytoplasmic sperm injection: a retrospective study.复发性流产患者接受非整倍体植入前基因检测与传统体外受精/卵胞浆内单精子注射的累积活产率比较分析:一项回顾性研究
J Ovarian Res. 2025 Jul 3;18(1):141. doi: 10.1186/s13048-025-01721-3.
3
The impact of unexplained spontaneous miscarriage history on cycle outcomes in patients undergoing in vitro fertilization: an analysis of 6535 patients.不明原因自然流产史对接受体外受精患者周期结局的影响:6535例患者的分析
BMC Pregnancy Childbirth. 2025 Jul 2;25(1):684. doi: 10.1186/s12884-025-07812-9.
4
Efficacy of therapeutic interventions for idiopathic recurrent pregnancy loss: a systematic review and network meta-analysis.特发性复发性流产治疗干预措施的疗效:一项系统评价和网状Meta分析
Front Med (Lausanne). 2025 May 14;12:1569819. doi: 10.3389/fmed.2025.1569819. eCollection 2025.
5
First-trimester Doppler Ultrasound for Predicting Successful Management of Pregnancy with Recurrent Pregnancy Losses Due to Antiphospholipid Syndrome and Thrombophilia: A Cohort Study.孕早期多普勒超声预测抗磷脂综合征和易栓症所致复发性流产妊娠成功管理:一项队列研究
J Hum Reprod Sci. 2024 Oct-Dec;17(4):261-268. doi: 10.4103/jhrs.jhrs_137_24. Epub 2024 Dec 23.
6
Prevalence of Antiphospholipid Antibody Syndrome Among Patients with Recurrent Pregnancy Loss: Impact of the Revised 2023 ACR/EULAR Antiphospholipid Syndrome Criteria.复发性流产患者中抗磷脂抗体综合征的患病率:2023年美国风湿病学会/欧洲抗风湿病联盟抗磷脂综合征修订标准的影响
J Clin Med. 2024 Dec 17;13(24):7698. doi: 10.3390/jcm13247698.
7
Hydroxychloroquine in recurrent pregnancy loss: data from a French prospective multicenter registry.羟氯喹治疗复发性流产:一项来自法国前瞻性多中心注册研究的数据。
Hum Reprod. 2024 Sep 1;39(9):1934-1941. doi: 10.1093/humrep/deae146.
8
Australasian recurrent pregnancy loss clinical management guideline 2024, part II.《2024年澳大拉西亚复发性流产临床管理指南》,第二部分。
Aust N Z J Obstet Gynaecol. 2024 Oct;64(5):445-458. doi: 10.1111/ajo.13820. Epub 2024 Jun 27.
9
A history of recurrent pregnancy loss is associated with increased perinatal complications, but not necessarily a longer birth interval: a population study spanning 18 years.复发性流产史与围产期并发症增加有关,但生育间隔不一定更长:一项为期18年的人群研究。
Hum Reprod. 2024 May 2;39(5):1105-1116. doi: 10.1093/humrep/deae029.
10
A review of the optimization of thyroid function, thrombophilia, immunity and uterine milieu treatment strategy for recurrent implantation failure and recurrent pregnancy loss.复发性植入失败和复发性流产的甲状腺功能、血栓形成倾向、免疫及子宫内环境治疗策略的优化综述。
Reprod Med Biol. 2024 Jan 18;23(1):e12561. doi: 10.1002/rmb2.12561. eCollection 2024 Jan-Dec.